https://news.cancerconnect.com/fda-approves-enhertu-for-two-new-indications-in-her2-positive-early-stage-breast-cancer/ 2026-05-18T15:02:36Z CancerConnect en FDA Approves Enhertu for Two New Indications in HER2-Positive Early-Stage Breast Cancer 2026-05-18T13:51:17Z Blog https://news.cancerconnect.com/can-mrd-assessment-with-ctdna-in-muscle-invasive-bladder-cancer-improve-outcomes/ 2026-05-18T13:22:07Z CancerConnect en Atezolizumab Plus ctDNA MRD Testing Wins FDA Approval to Improve Outcomes in Muscle-Invasive Bladder Cancer 2026-05-18T10:48:00Z Blog